US Stock MarketDetailed Quotes

SAGE Sage Therapeutics

Watchlist
  • 7.140
  • -0.040-0.56%
Close Feb 14 16:00 ET
  • 7.160
  • +0.020+0.28%
Post 20:01 ET
438.97MMarket Cap-1.08P/E (TTM)

About Sage Therapeutics Company

SAGE Therapeutics, Inc. is a biopharmaceutical company, which engages in providing solutions to brain health medicines. It focuses on diseases and disorders of the brain. Its products include ZURZUVAE and ZULRESSO. The company was founded by Steven Marc Paul and Douglas Covey on April 16, 2010 and is headquartered in Cambridge, MA.

Company Profile

SymbolSAGE
Company NameSage Therapeutics
Listing DateJul 18, 2014
Issue Price18.00
Founded2010
CEOMr. Barry E. Greene
MarketNASDAQ
Employees353
Fiscal Year Ends12-31
Address55 Cambridge Parkway
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-617-299-8380
Websitehttp://www.sagerx.com

Company Executives

  • Name
  • Position
  • Salary
  • Barry E. Greene
  • Director, President and Chief Executive Officer
  • 6.24M
  • Laura Gault, M.D.,PhD
  • Chief Medical Officer
  • 1.27M
  • Christopher Benecchi
  • Chief Operating Officer, Treasurer, Principal Financial and Accounting Officer
  • 2.28M
  • Dr. George S. Golumbeski, PhD
  • Independent Director
  • 412.55K
  • Dr. Steven M. Paul, M.D.
  • Independent Director
  • 420.05K
  • Jessica J. Federer
  • Independent Director
  • 962.23K
  • Michael F. Cola
  • Independent Director
  • 440.05K
  • James M. Frates
  • Independent Director
  • 435.05K
  • Geno J. Germano
  • Independent Director
  • 417.55K
  • Elizabeth Barrett
  • Independent Director
  • 425.05K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
PILOT
831175
+30.00%
XINGANJIANG
873167
+29.99%
Beijing Highlander Digital Technology
300065
+20.05%
4
Hangzhou Gaoxin Materials Technology
300478
+20.02%
5
Shijihengtong Technology
301428
+20.01%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call
Monetary Policy: Navigating the Fed's Rate Cut Cycle
Changing Fed policy is altering the market math for investors.